Quest Diagnostics
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 days.
- Recent price momentum is +23.3% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 3.4% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation D+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 25.7x | Better than 29% |
| Forward P/E | 24.2x | Better than 27% |
| Price / Sales | 2.4x | Better than 51% |
| P/E vs own 5-yr range | 98th pctl | Better than 5% |
Growth C+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 3.7% | Better than 42% |
| Net income CAGR (3Y) | 1.6% | Better than 44% |
| Free cash flow CAGR (3Y) | 1.1% | Better than 39% |
Profitability B-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 33.2% | Better than 37% |
| Operating margin | 14.1% | Better than 62% |
| Net margin | 9.0% | Better than 57% |
| Return on equity | 14.2% | Better than 66% |
| Return on invested capital | 8.6% | Better than 63% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 5.7% | Better than 84% |
| 6-month return | 32.8% | Better than 90% |
| 12-month return (ex latest month) | 28.1% | Better than 68% |
| Distance below 52-week high | 1.9% | Better than 98% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.0x | Better than 21% |
| Debt to assets | 40.6% | Better than 26% |
| Interest coverage | 5.8x | Better than 59% |
| Free cash flow / net income | 137.0% | Better than 60% |
Analyst View D
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 50.0% | Better than 26% |
| Upside to average target | 0.5% | Better than 4% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 259.09
- Open
- 262.00
- Day range
- 257.56 - 262.96
- Avg price
- 259.57
- Volume
- 1.37M
- Turnover
- 354.59M
- Turnover ratei
- 1.25%
- Volume ratioi
- 1.44
- Amplitudei
- 2.08%
- 52-week rangei
- 168.34 - 263.19
Valuation
- P/Ei
- 29.52
- P/E (TTM)i
- 25.73
- P/Bi
- 3.72
- EPSi
- 8.75
- Book value / shi
- 69.37
- Net profit
- 962.67M
- Net assets
- 7.63B
Share structure
- Market cap
- 28.42B
- Float capi
- 28.27B
- Shares out
- 110.02M
- Float sharesi
- 109.45M
Dividend & listing
- Div yield (TTM)i
- 1.31%
- Dividend (TTM)
- 3.38
- Listing date
- 1996-12-17
1.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-35.18M net over the window
Short interest
- Shares short
- 3.73M
- % of floati
- 3.39%
- Days to coveri
- 3.64
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Quest Diagnostics (DGX)?
Quest Diagnostics last traded at 258.28. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Quest Diagnostics's market cap?
About 28.42B.
What is the P/E ratio of Quest Diagnostics?
The trailing twelve-month P/E is 25.73, above its own 5-year average of 18.42 — toward the top of its historical range (98.49% percentile). See the Valuation tab for the full history.
Does Quest Diagnostics pay a dividend?
Yes. The trailing dividend yield is 1.31%. The 2025 payout was up 6.4% from 2024. See the Dividends tab for the full payment history.
Is Quest Diagnostics a buy according to analysts?
The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 259.63, which implies 0.5% upside from the current price. This is not investment advice.
What is Quest Diagnostics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Quest Diagnostics a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:27 · For reference only, not investment advice and not tailored to your situation.
Quest Diagnostics discussion 0 comments